Moore M - Search Results

1

Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study.

Hotte SJ, Oza A, Winquist EW, Moore M, Chen EX, Brown S, Pond GR, Dancey JE, Hirte HW. Hotte SJ, et al. Among authors: moore m. Ann Oncol. 2006 Feb;17(2):334-40. doi: 10.1093/annonc/mdj076. Epub 2005 Nov 10. Ann Oncol. 2006. PMID: 16284058 Free article. Clinical Trial.

2

Multicenter phase II trial of brequinar sodium in patients with advanced melanoma.

Natale R, Wheeler R, Moore M, Dallaire B, Lynch W, Carlson R, Grillo-Lopez A, Gyves J. Natale R, et al. Among authors: moore m. Ann Oncol. 1992 Sep;3(8):659-60. doi: 10.1093/oxfordjournals.annonc.a058298. Ann Oncol. 1992. PMID: 1450049 Free article. Clinical Trial.

3

A clinical and pharmacological study of 5-fluorouracil, leucovorin and interferon alfa in advanced colorectal cancer.

Moore MJ, Kaizer L, Erlichman C, Myers R, Feld R, Thiessen JJ, Fine S. Moore MJ, et al. Cancer Chemother Pharmacol. 1995;37(1-2):86-90. doi: 10.1007/BF00685633. Cancer Chemother Pharmacol. 1995. PMID: 7497602 Clinical Trial.

4

Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer.

Moore MJ, Osoba D, Murphy K, Tannock IF, Armitage A, Findlay B, Coppin C, Neville A, Venner P, Wilson J. Moore MJ, et al. J Clin Oncol. 1994 Apr;12(4):689-94. doi: 10.1200/JCO.1994.12.4.689. J Clin Oncol. 1994. PMID: 7512127 Clinical Trial.

5

Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group.

Mertens WC, Eisenhauer EA, Jolivet J, Ernst S, Moore M, Muldal A. Mertens WC, et al. Among authors: moore m. Ann Oncol. 1994 Feb;5(2):185-7. doi: 10.1093/oxfordjournals.annonc.a058776. Ann Oncol. 1994. PMID: 7910480 Free article. Clinical Trial.

6

A phase II study of 5-fluorouracil, leucovorin and interferon-alpha in advanced pancreatic cancer.

Moore MJ, Erlichman C, Kaizer L, Fine S. Moore MJ, et al. Anticancer Drugs. 1993 Oct;4(5):555-7. doi: 10.1097/00001813-199310000-00004. Anticancer Drugs. 1993. PMID: 8292812 Clinical Trial.

7

Multicenter phase II study of brequinar sodium in patients with advanced gastrointestinal cancer.

Moore M, Maroun J, Robert F, Natale R, Neidhart J, Dallaire B, Sisk R, Gyves J. Moore M, et al. Invest New Drugs. 1993 Feb;11(1):61-5. doi: 10.1007/BF00873913. Invest New Drugs. 1993. PMID: 8349438 Free article. Clinical Trial.

8

Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin.

Erlichman C, Moore M, Thiessen JJ, Kerr IG, Walker S, Goodman P, Bjarnason G, DeAngelis C, Bunting P. Erlichman C, et al. Among authors: moore m. Cancer Res. 1993 Oct 15;53(20):4837-42. Cancer Res. 1993. PMID: 8402670 Clinical Trial.

9

Gemcitabine in advanced renal cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group.

Mertens WC, Eisenhauer EA, Moore M, Venner P, Stewart D, Muldal A, Wong D. Mertens WC, et al. Among authors: moore m. Ann Oncol. 1993 Apr;4(4):331-2. doi: 10.1093/oxfordjournals.annonc.a058494. Ann Oncol. 1993. PMID: 8518225 Free article. Clinical Trial.

10

A phase I study of combined radiation therapy with 5-fluorouracil and low dose folinic acid in patients with locally advanced pancreatic or biliary carcinoma.

Hsue V, Wong CS, Moore M, Erlichman C, Cummings BJ, MacLeod M. Hsue V, et al. Among authors: moore m. Int J Radiat Oncol Biol Phys. 1996 Jan 15;34(2):445-50. doi: 10.1016/0360-3016(95)02032-2. Int J Radiat Oncol Biol Phys. 1996. PMID: 8567347 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,483 results

Search Page

Filters